News Daily News New ACC/AHA Hypertension Guidelines Still Urge Early Treatment but With Some Twists Yael L. Maxwell August 14, 2025
News Daily News POPCORN: Hemodialysis Patients Fare Well With Tailored PAD Therapies L.A. McKeown July 15, 2025
News Daily News AHA/ACC and Others Issue PAD Guideline Update With Focus on Collaborative Care L.A. McKeown May 17, 2024
News Conference News CRT 2024 CLIPPER: Emphasis on Faster Revascularization Could Change CLTI Care L.A. McKeown March 20, 2024
News Daily News No Safety Concerns Seen With Inclisiran in Large ORION Analysis Michael O'Riordan December 06, 2023
News Conference News VIVA 2023 ‘Dire’ Lack of Vascular Care in Underserved Areas Needs Creativity, Compassion L.A. McKeown November 03, 2023
News Conference News ESC 2023 New ESC Guidelines for CVD in Patients With Diabetes Cover Wide Ground Caitlin E. Cox August 30, 2023
News Daily News SI! School Program: No Improvements in Adolescent CV Health Caitlin E. Cox August 07, 2023
News Daily News Pitavastatin Cuts MACE in HIV-Infected Patients: REPRIEVE Michael O'Riordan July 25, 2023
News Daily News New Chronic Heart Disease Guidelines Update Roles of GDMT, Imaging, and Revascularization Michael O'Riordan July 20, 2023
News Daily News Two New Studies Highlight Lack of Diversity in Cardiovascular RCTs Michael O'Riordan July 11, 2023
News Conference News EAS 2023 With New LDL Goalposts in FH, Combo Therapy Must Start Early Michael O'Riordan May 29, 2023
News Daily News PROMISE II: Flow-Diverting Procedure May Save Limbs in CLTI L.A. McKeown March 29, 2023
News Daily News Food Insecurity Rose Over the Past 20 Years in Patients With CVD Yael L. Maxwell September 29, 2022
News Conference News ESC 2022 First Cardio-Oncology Guidelines From ESC Cover ‘Tremendous’ Territory L.A. McKeown August 26, 2022
News Daily News AHA Urges More Home-Based Dialysis in Advanced Kidney Failure Michael O'Riordan August 18, 2022
News Daily News ‘Redlining’ of Neighborhoods Left a Legacy of Poorer CV Health L.A. McKeown July 04, 2022
News Features Pricey Inclisiran Is Rolling Out: a ‘Buy-and-Bill’ Model May Smooth Its Path Michael O'Riordan January 17, 2022